Back to ACAD
ASSETMARK, INC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
10
Latest value
$757K
Q3 2026
Peak value
$1.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $4K |
| Q3 2025 | $1.1M |
| Q4 2025 | $6K |
| Q4 2025 | $868K |
| Q1 2026 | $5K |
| Q1 2026 | $672K |
| Q2 2026 | $9K |
| Q2 2026 | $751K |
| Q3 2026 | $7K |
| Q3 2026 | $757K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $757K | 4.3K | — | — |
| Q3 2026 | $7K | 370 | — | — |
| Q2 2026 | $751K | 4.3K | — | — |
| Q2 2026 | $9K | 345 | — | — |
| Q1 2026 | $672K | 4.1K | — | — |
| Q1 2026 | $5K | 245 | — | — |
| Q4 2025 | $868K | 4.8K | — | — |
| Q4 2025 | $6K | 222 | — | — |
| Q3 2025 | $1.1M | 6.4K | — | — |
| Q3 2025 | $4K | 197 | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M